Catalent | Beneficio Bruto En Ventas

Gross Profit On Sales Cambio Fecha
Agilent USD 908M 7M 2023-12
AstraZeneca USD 9.43B 15M 2023-09
Bristol-Myers Squibb USD 8.77B 294M 2023-12
Bruker USD 430.3M 46.4M 2023-12
Catalent USD 171M 2M 2023-12
Centene USD 4.55B 21M 2023-09
Charles River Laboratories USD 370.75M 5.32M 2023-12
Cigna USD 6.48B 372M 2023-09
Dentsply International USD 522M 27M 2023-12
Eli Lilly USD 7.57B 73.1M 2023-12
Hologic USD 567.5M 67.2M 2023-12
Illumina USD 674M 10M 2023-12
IQVIA Holdings USD 1.39B 80M 2023-12
Laboratory Of America USD 821.4M 29.8M 2023-12
Lonza CHF 1.11B 134M 2023-06
McKesson USD 2.99B 32M 2023-09
Merck EUR 3.01B 152M 2023-09
Merck USD 11.29B 441M 2023-12
Mettler Toledo International USD 551.64M 7.9M 2023-12
Pfizer USD 7.58B 3.26B 2023-12
Repligen USD 67.61M 8.34M 2023-12
Revvity USD 383.48M 10.96M 2023-12
Roche Holding CHF 22.16B 123M 2023-06
Supernus Pharmaceuticals USD 144.69M 10.41M 2023-12
Waters USD 420.28M 19.22M 2023-09
West Pharmaceutical Services USD 278.2M 10.1M 2023-12



Catalent Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2024.